QCM
IMVT icon

Quantinno Capital Management’s Immunovant IMVT Stock Holding History

Quantinno Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
46,005
+5,975
+15% +$182K ﹤0.01% 2076
2026
Q1 		$994K Buy
40,030
+25,787
+181% +$668K ﹤0.01% 2169
2025
Q4 		$362K Buy
14,243
+2,755
+24% +$61.4K ﹤0.01% 2705
2025
Q3 		$185K Buy
+11,488
New +$186K ﹤0.01% 2783

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quantinno Capital Management's IMVT Position: Q2 2026 in Review

Quantinno Capital Management increased its Immunovant (IMVT) stake by 15% in Q2 2026, buying an estimated $182K and bringing the position to 46,005 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

Quantinno Capital Management first reported a position in IMVT in Q3 2025 and has held it in 4 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Quantinno Capital Management held 46,005 shares of Immunovant worth $1.77M as of Q2 2026.
  • Quantinno Capital Management bought 5,975 Immunovant shares in Q2 2026, an estimated $182K.
  • Immunovant made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2076 holding.
  • Quantinno Capital Management first reported a position in Immunovant in Q3 2025 and has held it in 4 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.